VIRAL SAFETY BY DESIGN FOR CELL AND GENE THERAPY PRODUCTS Together with product efficacy, product safety is an essential characteristic of any medicinal product including cell and gene therapy (C>) biologics. Adventitious agents (viruses, bacteria, mycoplasma,…
Watch the replay of our webinar – Accelerated vaccines development and production: in-process NGS QC testing for risk mitigations
Archived version of our webinar: Accelerated vaccines development and production: in-process NGS QC testing for risk mitigations Appropriate safety testing is an important part of vaccine development and production.
Watch the replay of our webinar – The Benefits of NGS-Based Quality Control for Routine Biologics testing using GLP-Certified Solutions
PathoQuest is offering a GLP-certified (grade A) NGS solutions further to the successful inspection of ANSM in December 2019. Watch why NGS is a fast and reliable quality control test for adventitious agents’ detection and viral stock characterization that supplement and replace sub-optimal traditional methods, in particular for ATMPs’ testing.
Learn more about the use of high-throughput sequencing (HTS) to identify viral contamination of biological products with a new approach to differentiate inert versus active viral sequences to assist customers with de-risking the production process.